Julian Itzcovitz

Novian Health, Inc. provides minimally invasive treatment for cancerous and non-cancerous tumors. The firm develops tested, and patented a treatment procedure, Novilase, which uses interstitial laser therapy (controlled heating) for the ablation of breast tumors as an alternative to the surgically invasive, traditional lumpectomy. It has operations in France and The United States of America. The company was founded by Kambiz Dowlatshahi in 1991 and is headquartered in Chicago, IL.

Novian Health, Inc. provides minimally invasive treatment for cancerous and non-cancerous tumors. The firm develops tested, and patented a treatment procedure, Novilase, which uses interstitial laser therapy (controlled heating) for the ablation of breast tumors as an alternative to the surgically invasive, traditional lumpectomy. It has operations in France and The United States of America. The company was founded by Kambiz Dowlatshahi in 1991 and is headquartered in Chicago, IL.

Novian Health, Inc. provides minimally invasive treatment for cancerous and non-cancerous tumors. The firm develops tested, and patented a treatment procedure, Novilase, which uses interstitial laser therapy (controlled heating) for the ablation of breast tumors as an alternative to the surgically invasive, traditional lumpectomy. It has operations in France and The United States of America. The company was founded by Kambiz Dowlatshahi in 1991 and is headquartered in Chicago, IL.

Novian Health, Inc. provides minimally invasive treatment for cancerous and non-cancerous tumors. The firm develops tested, and patented a treatment procedure, Novilase, which uses interstitial laser therapy (controlled heating) for the ablation of breast tumors as an alternative to the surgically invasive, traditional lumpectomy. It has operations in France and The United States of America. The company was founded by Kambiz Dowlatshahi in 1991 and is headquartered in Chicago, IL.

Novian Health, Inc. provides minimally invasive treatment for cancerous and non-cancerous tumors. The firm develops tested, and patented a treatment procedure, Novilase, which uses interstitial laser therapy (controlled heating) for the ablation of breast tumors as an alternative to the surgically invasive, traditional lumpectomy. It has operations in France and The United States of America. The company was founded by Kambiz Dowlatshahi in 1991 and is headquartered in Chicago, IL.